➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Merck
Harvard Business School
McKinsey
McKesson

Last Updated: September 22, 2021

DrugPatentWatch Database Preview

Details for Patent: 7,910,767


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 7,910,767 protect, and when does it expire?

Patent 7,910,767 protects VYZULTA and is included in one NDA.

This patent has fifty-two patent family members in thirty-seven countries.

Summary for Patent: 7,910,767
Title:Prostaglandin derivatives
Abstract: Prostaglandin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.
Inventor(s): Ongini; Ennio (Milan, IT), Chiroli; Valerio (Milan, IT), Benedini; Francesca (Milan, IT), Soldato; Piero Del (Monza, IT)
Assignee: Nicox S.A. (Sophia Antipolis Cedex, FR)
Application Number:12/613,985
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Compound; Process; Dosage form;

Drugs Protected by US Patent 7,910,767

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bausch And Lomb VYZULTA latanoprostene bunod SOLUTION/DROPS;OPHTHALMIC 207795-001 Nov 2, 2017 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y Y REDUCTION OF INTRAOCULAR PRESSURE (IOP) IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,910,767

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
04100001Jan 5, 2004

International Family Members for US Patent 7,910,767

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 047081 ⤷  Free Forever Trial
Argentina 098931 ⤷  Free Forever Trial
Australia 2004313688 ⤷  Free Forever Trial
Brazil PI0418245 ⤷  Free Forever Trial
Canada 2551409 ⤷  Free Forever Trial
China 100469765 ⤷  Free Forever Trial
China 1906159 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Johnson and Johnson
Express Scripts
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.